Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.
Visit our Writing Guide or this topic page for additional help.
Timeline
Further Resources
Title
Author
Link
Type
Date
News
Title
Author
Date
Publisher
Description
BioSpace
June 15, 2021
BioSpace
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), today announced that Dr. John Laffey has been appointed to its ARDS Scientific Advisory Board (SAB), effective immediately.
Citius Pharmaceuticals, Inc.
June 15, 2021
www.prnewswire.com:443
/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and...
BioSpace
May 18, 2021
BioSpace
Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced the hiring of Dan Gincel, Ph.D. as Senior Vice President, Strategic Collaborations & Scientific Affairs.
Research and Markets
December 14, 2020
www.prnewswire.com:443
/PRNewswire/ -- The "Acute Respiratory Distress Syndrome (ARDS) Market Insight, Epidemiology and Market Forecast - 2030" report has been added to...
FinancialNewsMedia.com
December 9, 2020
www.prnewswire.com:443
/PRNewswire/ -- All around the globe, scientists are working hard to develop effective treatments, therapies and vaccines to halt the COVID-19 pandemic....
SHOW MORE